NEUROLOGY 2004;62:2005-2009
© 2004 American Academy of Neurology
Apolipoprotein E controls the risk and age at onset of Parkinson disease
Y. J. Li, PhD,
M. A. Hauser, PhD,
W. K. Scott, PhD,
E. R. Martin, PhD,
M. W. Booze, BS,
X. J. Qin, PhD,
J. W. Walter, PhD,
M. A. Nance, MD,
J. P. Hubble, MD,
W. C. Koller, MD,
R. Pahwa, MD,
M. B. Stern, MD,
B. C. Hiner, MD,
J. Jankovic, MD,
C. G. Goetz, MD,
G. W. Small, MD,
F. Mastaglia, MD,
J. L. Haines, PhD,
M. A. Pericak-Vance, PhD* and
J. M. Vance, MD PhD*
From the Department of Medicine and Center for Human Genetics (Drs. Li, Hauser, Scott, Martin, Qin, Walter, Pericak-Vance, and Vance, and M.W. Booze), Duke University Medical Center, Durham, NC; Struthers Parkinson Center (Dr. Nance), Golden Valley, MN; Department of Neurology (Dr. Hubble), Ohio State University, Columbus; Department of Neurology (Dr. Koller), University of Miami School of Medicine, FL; Department of Neurology (Dr. Pahwa), University of Kansas Medical Center, Kansas City; Department of Neurology (Dr. Stern), University of Pennsylvania Health System, Philadelphia; Department of Neurology (Dr. Hiner), Marshfield Clinic, Marshfield, WI; Department of Neurology (Dr. Jankovic), Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (Dr. Goetz), Rush-Presbyterian-St. Luke’s Hospital, Chicago, IL; Departments of Psychiatry & Biobehavioral Sciences and Neurology (Dr. Small), University of California, Los Angeles; Centre for Neuromuscular and Neurological Disorders (Dr. Mastaglia), University of Western Australia, Perth; and Center for Human Genetics Research (Dr. Haines), Vanderbilt University Medical Center, Nashville, TN.
Address correspondence and reprint requests to Dr. Yi-Ju Li, Center for Human Genetics, Duke University Medical Center, DUMC Box 3445, Durham, NC 27710; e-mail: yiju.li{at}duke.edu
Background: Similarities between Alzheimer disease (AD) and Parkinson disease (PD) suggest a possible role for apolipoprotein E (APOE) in PD. Most previous studies seeking to establish such a link used case-control datasets and results have been inconsistent.
Objective: To investigate APOE’s role in PD using family-based association analyses.
Methods: APOE functional polymorphisms were genotyped for 658 PD affected families, including 282 multiplex and 376 singleton families. The pedigree disequilibrium test (PDT) and the genotype-PDT were used to test the risk effect of APOE. The Monks-Kaplan test was used to evaluate the effect of APOE on age at onset of PD.
Results: APOE was significantly associated with risk of developing PD. Stratified analysis revealed that APOE was most strongly associated with families with a positive PD family history (global p = 0.003). Like AD, the APOE-4 allele increases disease risk while the APOE-3 allele decreases risk. We detected a positive association of APOE-3 (p = 0.019) and a negative association of APOE-4 (p = 0.015) with age at onset in PD.
Conclusions: The APOE-4 allele increases risk and decreases age at onset of PD, an association that may not be dependent upon cognitive impairment.
Received October 5, 2003.
Accepted in final form January 23, 2004.
*These authors contributed equally to the manuscript.
This article has been cited by other articles:
|
|
|
|
 
M. W. Kurz, G. Dekomien, O. B. Nilsen, J. P. Larsen, D. Aarsland, and G. Alves
APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
J Geriatr Psychiatry Neurol,
September 1, 2009;
22(3):
166 - 170.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Agosta, K. A. Vossel, B. L. Miller, R. Migliaccio, S. J. Bonasera, M. Filippi, A. L. Boxer, A. Karydas, K. L. Possin, and M. L. Gorno-Tempini
Apolipoprotein E {varepsilon}4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia
PNAS,
February 10, 2009;
106(6):
2018 - 2022.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Verbaan, S. Boesveldt, S. M. van Rooden, M. Visser, J. Marinus, M. G. Macedo, Y. Fang, P. Heutink, H. W. Berendse, and J. J. van Hilten
Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?
Neurology,
December 2, 2008;
71(23):
1877 - 1882.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Xu, D. Walker, A. Bernardo, J. Brodbeck, M. E. Balestra, and Y. Huang
Intron-3 Retention/Splicing Controls Neuronal Expression of Apolipoprotein E in the CNS
J. Neurosci.,
February 6, 2008;
28(6):
1452 - 1459.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B A Parmenter, D R Denney, S G Lynch, L S Middleton, and L M Harlan
Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms
Multiple Sclerosis,
January 1, 2007;
13(1):
25 - 32.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. M. Burwick, P. P. Ramsay, J. L. Haines, S. L. Hauser, J. R. Oksenberg, M. A. Pericak-Vance, S. Schmidt, A. Compston, S. Sawcer, R. Cittadella, et al.
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers
Neurology,
May 9, 2006;
66(9):
1373 - 1383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Mahley, K. H. Weisgraber, and Y. Huang
Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease
PNAS,
April 11, 2006;
103(15):
5644 - 5651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Paisan-Ruiz, A. E. Lang, T. Kawarai, C. Sato, S. Salehi-Rad, G. K. Fisman, T. Al-Khairallah, P. St George-Hyslop, A. Singleton, and E. Rogaeva
LRRK2 gene in Parkinson disease: Mutation analysis and case control association study
Neurology,
September 13, 2005;
65(5):
696 - 700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. L. de Lau, C. M. A. Schipper, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler
Prognosis of Parkinson Disease: Risk of Dementia and Mortality: The Rotterdam Study
Arch Neurol,
August 1, 2005;
62(8):
1265 - 1269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Tsuang, R. K. Wilson, O. L. Lopez, E. K. Luedecking-Zimmer, J. B. Leverenz, S. T. DeKosky, M. I. Kamboh, and R. L. Hamilton
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease
Neurology,
February 8, 2005;
64(3):
509 - 513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
